Carroll Financial Associates’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$342K Buy
3,800
+2,000
+111% +$135K 0.02% 300
2021
Q3
$87K Hold
1,800
﹤0.01% 570
2021
Q2
$90K Buy
1,800
+800
+80% +$39.4K 0.01% 611
2021
Q1
$39K Sell
1,000
-500
-33% -$19.4K ﹤0.01% 825
2020
Q4
$43K Hold
1,500
﹤0.01% 739
2020
Q3
$32K Hold
1,500
﹤0.01% 751
2020
Q2
$12K Hold
1,500
﹤0.01% 984
2020
Q1
$7K Hold
1,500
﹤0.01% 1029
2019
Q4
$21K Buy
+1,500
New +$30.8K ﹤0.01% 860
2019
Q3
Sell
-1,500
Closed -$29K 1530
2019
Q2
$29K Hold
1,500
﹤0.01% 719
2019
Q1
$39K Hold
1,500
﹤0.01% 609
2018
Q4
$38K Hold
1,500
﹤0.01% 533
2018
Q3
$47K Hold
1,500
0.01% 515
2018
Q2
$56K Hold
1,500
0.01% 476
2018
Q1
$48K Buy
+1,500
New +$27.9K 0.01% 495

Other funds holding BXC

Carroll Financial Associates's BXC Position: Q4 2021 in Review

Carroll Financial Associates increased its BlueLinx (BXC) stake by 111% in Q4 2021, buying an estimated $135K and bringing the position to 3,800 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #300.

Carroll Financial Associates first reported a position in BXC in Q1 2018 and has held it in 15 quarters since. 150 funds tracked by Wall St. Rank hold BXC as of Q4 2021.

  • Carroll Financial Associates held 3,800 shares of BlueLinx worth $342K as of Q4 2021.
  • Carroll Financial Associates bought 2,000 BlueLinx shares in Q4 2021, an estimated $135K.
  • BlueLinx made up 0.02% of Carroll Financial Associates's portfolio in Q4 2021, its #300 holding.
  • Carroll Financial Associates first reported a position in BlueLinx in Q1 2018 and has held it in 15 quarters since.
  • 150 funds tracked by Wall St. Rank held BlueLinx as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.